- А. Kisheva, Y. Yotov, S. Ognyanov, P. Makaveeva
Role of mineralocorticoid receptor blockade in COVID-19. Cardiovascular diseases, 2021, 52, № 2, 3-8
- N. Hvarchanova, S. Stoeva, M. Radeva-Ilieva, M. Georgieva
New pharmacotherapeutic options for the treatment of heart failure with reduced ejection fraction Cardiovascular diseases, 2021, 52, № 2, 9-17
- Z. Vassileva
Cardiovascular diseases – socio-economic impact. Cardiovascular diseases, 2021, 52, № 2,18-22
- S. Naydenov
Combined therapeutic approach in patients with arterial hypertension and dyslipidemia. Cardiovascular diseases, 2021, 52, № 2, 23-28
- T. Yaneva-Sirakova, R. Dodova, R. Kaneva, R. Tzveova, R. Ivanova, D. Vassilev
Screening for fibromuscular dysplasia in Bulgarian patients and genetic aspects. Cardiovascular diseases, 2021, 52, № 2, 29-38
- I. Simova, D. Hristova, B. Goranova, D. Goranova, S. Mehmed, N. Dimitrov, T. Vekov
Life after COVID-19: initial results of the first national campaign in Bulgaria. Cardiovascular diseases, 2021, 52, № 2, 39-43